NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs042230066

Registered date:04/08/2023

Exploratory study of 24-hour intraocular pressure fluctuation profile in patients with primary open-angle glaucoma and healthy subjects with contact lens sensor

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPrimary Open Angle Glaucoma (POAG)
Date of first enrollment14/11/2023
Target sample size150
Countries of recruitment
Study typeInterventional
Intervention(s)Triggerfish will be placed in eyes with advanced visual field defects and IOP fluctuations will be recorded for 24 consecutive hours to predict the visual field progression. In untreated POAG patients, initial and second Triggerfish measurements after eye drop treatment will be used to assess the effectiveness of the treatment intervention

Outcome(s)

Primary OutcomeObtain 24-hour IOP fluctuation pattern and various profile parameters (Acrophase, Amplitude, Bathyphase etc.)
Secondary OutcomeEvaluation for visual acuity test, slit lamp microscopy, intraocular pressure and adverse events

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximum< 80age old
GenderBoth
Include criteria1)Subjects of male or female over 20 to 79 years old 2)Patients with primary open-angle glaucoma who have been followed up for 2 years or more at the medical in-stitution, or patients who have been diagnosed with primary open-angle glaucoma for the first time, or healthy subjects who have no findings suggesting glaucoma and have no other eye disease. 3)Signed informed consent for the investigation
Exclude criteria1) Patients with a static visual field testing (HFA 30-2 or 24-2 program) MD value of -12.0 dB or less in the study eye 2) The spherical diopter of the inspected eye is plus minus 6.00D, and the cylinder diopter is out of the range of plus minus 3.00D 3) In addition to glaucoma, existence with another eye diseases that affect the results of visual field testing and three-dimensional fundus image analysis using optical coherence tomography in the study eye 4) Glaucoma surgery, glaucoma laser treatment, refractive surgery within 6 months before the start of the study 5) Allergy to corneal anesthetic 6) Patients with implanted cardiac pacemakers or other electro-medical devices 7) Patients with eye infections 8) Patients with acute and subacute inflammation of the anterior segment of the eye 9) Patients with corneal, conjunctival, or eyelid abnormalities,corneal hypoesthesia, lacrimal insufficiency, or tear secretion insufficiency, or lacrimal disease to the extent that it affects the use of the sensor. 10) Patients with a history of complications related to contact lens wear 11) Patients with allergic diseases to silicone materials 12) Any person who is in an environment where the sensor is contaminated by spray, smoke, dust, steam, etc. 13) Patients with complications such as serious cardiac, hepatic, renal, pulmonary, or hematological diseases that are considered unsuitable for clinical research. (14) Those who have participated in other clinical research or clinical trials (including those outside the field of ophthalmology) within the past six months. (15) Any other person whom the principal investigator or subphysician determines to be unsuitable for the subject, or who the principal investigator or sub-physician determines to be unsuitable for wearing contact lenses

Related Information

Contact

Public contact
Name Tomomi Higashide
Address 13-1 Takara-machi, Kanazawa,Ishikawa Ishikawa Japan 920-8641
Telephone +81-76-265-2403
E-mail eyetomo@med.kanazawa-u.ac.jp
Affiliation Kanazawa University Hospital
Scientific contact
Name Tomomi Higashide
Address 13-1 Takara-machi, Kanazawa,Ishikawa Ishikawa Japan 920-8641
Telephone +81-76-265-2403
E-mail eyetomo@med.kanazawa-u.ac.jp
Affiliation Kanazawa University Hospital